KRYS (STOCKS)
Krystal Biotech, Inc. Common Stock
$332.632200
-0.227800 (-0.07%)
Prev close: $332.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Krish S. Krishnan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,301.63M
- Employees
- 275
- P/E (TTM)
- 41.71
- P/B (TTM)
- 7.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.79 | $1.69 | +0.1013 | +6.00% |
|
Mar 2026 (Q1)
|
$1.83 | $1.45 | +0.3814 | +26.33% |
|
Dec 2025 (Q4)
|
$1.70 | $1.44 | +0.2633 | +18.33% |
|
Sep 2025 (Q3)
|
$2.66 | $1.11 | +1.5527 | +140.22% |
Financial Statements
| Revenues | $440.48M |
| Benefits Costs and Expenses | $213.87M |
| Costs And Expenses | $213.87M |
| Operating Expenses | $242.73M |
| Selling, General, and Administrative Expenses | $159.89M |
| Research and Development | $59.23M |
| Other Operating Expenses | $23.62M |
| Operating Income/Loss | $197.75M |
| Income/Loss From Continuing Operations After Tax | $241.47M |
| Income/Loss From Continuing Operations Before Tax | $226.62M |
| Income Tax Expense/Benefit | -$14.85M |
| Net Income/Loss | $241.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $241.47M |
| Net Income/Loss Available To Common Stockholders, Basic | $241.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $8.27 |
| Diluted Earnings Per Share | $7.98 |
| Basic Average Shares | 87,821,000 |
| Diluted Average Shares | 91,119,000 |
| Assets | $1.50B |
| Current Assets | $1.06B |
| Cash | $845.60M |
| Inventory | $45.56M |
| Other Current Assets | $168.49M |
| Noncurrent Assets | $441.00M |
| Fixed Assets | $153.78M |
| Other Non-current Assets | $287.23M |
| Liabilities | $141.52M |
| Current Liabilities | $127.40M |
| Accounts Payable | $6.54M |
| Other Current Liabilities | $120.85M |
| Noncurrent Liabilities | $14.13M |
| Equity | $1.36B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.36B |
| Liabilities And Equity | $1.50B |
| Net Cash Flow From Operating Activities | $272.34M |
| Net Cash Flow From Operating Activities, Continuing | $272.34M |
| Net Cash Flow From Investing Activities | -$218.29M |
| Net Cash Flow From Investing Activities, Continuing | -$218.29M |
| Net Cash Flow From Financing Activities | $23.97M |
| Net Cash Flow From Financing Activities, Continuing | $23.97M |
| Exchange Gains/Losses | -$4.11M |
| Net Cash Flow | $73.91M |
| Net Cash Flow, Continuing | $78.02M |
| Comprehensive Income/Loss | $235.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $235.97M |
| Other Comprehensive Income/Loss | $235.97M |